Morepen Laboratories (MOREPENLAB) 52 Week High Streak: Fourth Consecutive Session
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Morepen Laboratories 52 Week High Streak has now extended to a fourth consecutive session, with the stock rising 18.6% across the streak and touching a fresh 52-week high of Rs 140.9. The latest price action confirms a repeated one-year-high pattern, but it does not by itself establish a company-specific catalyst for the move. According to latest Univest data, the stock last traded at Rs 140.9.
The previous close was Rs 135.3, while the day opened at Rs 135.8 and moved between Rs 135.6 and Rs 140.9. Turnover for the ongoing move sits alongside a market capitalisation of Rs 7,326.14 crore, which helps frame the Morepen Laboratories 52 Week High Streak as more than a one-day breakout. For readers, the repeated-high pattern matters because it shows a sustained price sequence, not just a single fresh peak.
Morepen Laboratories 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 140.9 |
| Previous Close | Rs 135.3 |
| Today's Move | +Rs 5.6 (+4.14%) |
| Open | Rs 135.8 |
| High | Rs 140.9 |
| Low | Rs 135.6 |
| Market Capitalisation | Rs 7,326.14 crore |
Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 140.9 versus the previous close of Rs 135.3, a rise of 4.14%. The stock opened at Rs 135.8, reached a high of Rs 140.9 and touched a low of Rs 135.6.
Morepen Laboratories share price today was at Rs 140.9, which is Rs 5.6 higher than the previous close and a 4.14% rise. The Morepen Laboratories 52 Week High Streak is visible in the day’s path as the stock opened near the prior finish at Rs 135.8, stayed above the low of Rs 135.6 and matched the session high at Rs 140.9. That means the latest price was at the top of the day’s range when the timestamped market reading was taken.
The move also keeps the stock in focus among 52 week high stocks because the current price equals the latest 52-week high. Market capitalisation stands at Rs 7,326.14 crore. For a reader tracking the Morepen Laboratories 52 Week High Streak, the important point is not only the single-session change, but the fact that the price has now reset its one-year peak on four consecutive sessions, which makes the sequence notable in the stock market today context.
Morepen Laboratories 52 Week High Streak: Consecutive High Analysis
The Morepen Laboratories 52 Week High Streak has now run for a fourth consecutive session, and that is the core fact to watch. The stock has climbed 18.6% across the streak since the first breakout on 30 September 2026, and the present 52-week high of Rs 140.9 is the current reference point. The latest figures confirm the pattern of repeated fresh highs, while the data provided does not identify a separate trigger for why the streak has continued.
For investors, the distinction between a single fresh high and a repeated sequence matters. A one-day move can be a standalone event, but the Morepen Laboratories 52 Week High Streak shows the stock has reset its yearly high on each of four trading sessions in a row. That makes the current read more useful as a trend of price discovery than as an isolated headline. The streak is also important because the latest high is the same as the current last traded price, showing the market is still testing the peak.
What the Repeated 52-Week Highs Show
The Morepen Laboratories 52 Week High Streak shows persistence in price setting, but it does not tell readers why the move is unfolding. The available numbers confirm that the stock has set a new one-year high on four straight sessions and that the cumulative gain is 18.6%, which is the key quantitative difference from a Day-1 breakout article. In simple terms, the streak itself is the story, not an assumed reason behind it.
That is why the repeated highs deserve separate analysis. The Morepen Laboratories 52 Week High Streak says the stock has moved beyond its earlier yearly peak and kept doing so over several sessions. Yet the numbers alone do not establish whether the move reflects a corporate event, a change in outlook, or some other market factor. Readers should therefore treat the pattern as a confirmed price sequence and watch whether the stock continues to hold above its earlier reference levels.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,326.14 crore |
| P/E Ratio | 52.76x |
| P/B Ratio | 5.69x |
| ROE | 7.96% |
| ROCE | 10.19% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.15% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 52.76x, P/B 5.69x, ROE 7.96%, ROCE 10.19%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 7,326.14 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 52.76x, P/B at 5.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.61x, median ROE of 11.78%, median ROCE of 13.65%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 52.76x |
| Benchmark Median P/E | 31.61x |
| Benchmark Average P/E | 47.95x |
| Benchmark P/E Range | 3.58x to 668.09x |
| Company P/B Ratio | 5.69x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 7.96% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 10.19% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 7,326.14 crore |
| Benchmark Median Market Cap | Rs 782.8 crore |
Morepen Laboratories Ltd. (MOREPENLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 52.76x, which is above the benchmark median of 31.61x, a difference of +66.91%. On its own, the P/E gap is a valuation reference point, not a trading call.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.78%, a difference of -32.43%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.65%, a difference of -25.35%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,275.13 | 51.57 | 5.7 | 12.11 | 17.4 |
| Supriya Lifescience Ltd. | SUPRIYA | 7,241.44 | 36.5 | 5.93 | 19.06 | 25.3 |
| Sanofi India Ltd. | SANOFI | 6,981.85 | 21.52 | 8.43 | 44.5 | 55.46 |
| SYMBIOTEC PHARMALAB LTD | SYMBIOTEC | 7,706.24 | 68.31 | 5.01 | 11.22 | 12.41 |
| Innova Captab Ltd. | INNOVACAP | 6,681.58 | 41.93 | 5.77 | 13.75 | 15.04 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 52.76x compared with the displayed peer median of 41.93x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 7.96% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 7,326.14 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- The Morepen Laboratories 52 Week High Streak has reached a fourth consecutive session, which makes the price sequence worth tracking closely.
- The stock has moved 18.6% across the streak, giving investors a cumulative figure rather than only a single-day move.
- The latest price of Rs 140.9 matches the current 52-week high, so the stock is still testing the peak.
- Valuation is richer than the Healthcare industry median on both P/E and P/B, which changes the way the streak is read.
- Operating return ratios remain below the industry median, so the streak is not being matched by stronger return metrics.
About Morepen Laboratories Ltd.
Morepen Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare. For readers following the Morepen Laboratories 52 Week High Streak, the business context matters because the stock is being assessed inside a sector that is already diverse on valuation and return ratios. The company’s market cap is Rs 7,326.14 crore, and the latest P/E, P/B, ROE and ROCE readings give the market a framework for comparing the streak with fundamentals.
The company profile here is intentionally brief because the key question is how the repeated one-year highs fit into the existing business backdrop. In that sense, the Morepen Laboratories 52 Week High Streak is best read alongside valuation and sector placement, not as a standalone corporate summary.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is the current Morepen Laboratories 52 Week High Streak?
Ans. Morepen Laboratories 52 Week High Streak is now four consecutive sessions. The stock has set a fresh 52-week high on each of those sessions, making this a repeated-high pattern rather than a one-off breakout.
How much has Morepen Laboratories moved across the streak?
Ans. The Morepen Laboratories 52 Week High Streak has delivered a cumulative rise of 18.6%. That figure captures the full run from the first breakout session to the latest fresh 52-week high.
What is the latest 52-week high for Morepen Laboratories?
Ans. The latest 52-week high for Morepen Laboratories is Rs 140.9. The current price is at that level, so the stock is trading at its fresh one-year peak in the latest market reading.
Is a company-specific catalyst confirmed for the repeated highs?
Ans. No company-specific catalyst is confirmed by the price data alone. The Morepen Laboratories 52 Week High Streak confirms the pattern of repeated highs, but the numbers do not establish why the stock kept resetting its peak.
How does Morepen Laboratories compare with its industry on valuation?
Ans. Morepen Laboratories trades above the industry median on both P/E and P/B. In the context of the Morepen Laboratories 52 Week High Streak, that means the stock is priced more richly than the typical Healthcare peer in the benchmark set.
How do the return ratios compare with the industry median?
Ans. ROE and ROCE for Morepen Laboratories are below the industry median. That matters because the Morepen Laboratories 52 Week High Streak is happening while operating return metrics remain softer than the broader industry benchmark.
What should investors monitor next?
Ans. Investors should watch whether Morepen Laboratories continues to hold near the fresh high, how the valuation read evolves, and whether upcoming business updates alter the context around the Morepen Laboratories 52 Week High Streak.
Why is the streak important for market watchers?
Ans. The Morepen Laboratories 52 Week High Streak is important because it shows four straight sessions of new one-year highs. That repeated pattern is more informative than a single-day breakout when readers are assessing the stock market today.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
If you want to follow the Morepen Laboratories 52 Week High Streak beyond this update, keep an eye on the latest price, the current 52-week high and the relative valuation view against Healthcare peers. The stock’s repeated high pattern makes it useful to monitor how price behaves around the present peak as fresh market readings come in.
Morepen Laboratories share price updates on Univest can help readers compare the streak with key valuation ratios, sector context and peer benchmarks in one place. For anyone screening 52 week high stocks, the current sequence is a clear case to watch.
